Manufacturing
Pharmaceutical
Biopharmaceutical

Mallinckrodt

$6.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-1.73%) Today
$0.00 (0.00%) As of 5:59 PM EDT after-hours

Why Robinhood?

You can buy or sell Mallinckrodt and other stocks, options, ETFs, and crypto commission-free!

About MNK

MALLINCKRODT PUBLIC LIMITED COMPANY, also called Mallinckrodt, is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. Read More It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Staines-Upon-Thames, the United Kingdom.

Employees
3,700
Headquarters
Staines-Upon-Thames, Surrey
Founded
2015
Market Cap
578.07M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.92M
High Today
$6.88
Low Today
$6.07
Open Price
$6.72
Volume
6.16M
52 Week High
$36.65
52 Week Low
$6.07

Collections

Manufacturing
Pharmaceutical
Biopharmaceutical
Health
Medical
Technology
2013 IPO

MNK News

Washington PostJul 19

Internal drug company emails show indifference to opioid epidemic

73
Wall Street JournalJul 16

Mallinckrodt Halts Lou Gehrig’s Disease Trial

141
ReutersJul 15

U.S. says Mallinckrodt owes bigger rebates after massive price hike

162

MNK Earnings

$1.10
$1.46
$1.82
$2.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 6, Pre-Market

More MNK News

Yahoo FinanceJun 24

Mallinckrodt Achieves 50 Percent Enrollment for Phase 2B Trial Investigating the Use of Acthar® Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis

191
Barron'sJun 24

The U.S. Gets Hundreds of Millions From Big Pharma in Co-Pay Settlements

179
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.